Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments

8 hours ago
Alex Pearon

McGill University researchers have built tiny particle carriers that can shuttle cancer drugs straight to diseased lymph nodes without touching healthy tissue,…

Rail Vision Ltd. (NASDAQ: RVSN) Subsidiary Advances Quantum AI Strategy with New Neural Decoder Breakthrough

9 hours ago

Quantum Transportation’s system represents a patented prototype machine-learning-driven decoder aimed at addressing the complex challenges of universal quantum error correction.…

Datavault AI Inc. (NASDAQ: DVLT) Expanded Digital Engagement Through Dream Bowl Meme Token, Major Event Partnership

2 days ago

Wellgistics sponsored Dream Bowl 2026 and participated in the Datavault AI shareholder distribution plan for the Dream Bowl 2026 meme…

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technologies, Advancing the LiGHT System for Next-Generation Cancer Care

2 days ago

LIXTE has acquired Liora Technologies Europe Ltd., securing its proprietary LiGHT system for advanced proton therapy treatment Liora works at…

Canadian Defense Strategy Categorizes Quantum Computing as a High-Value Sector

2 days ago

Ottawa's latest defense industrial roadmap treats quantum computing as a strategic priority requiring government protection and accelerated development. Quantum sits…

GridAI Corp. (NASDAQ: GRDX) Committed to Optimization of Energy Management to Meet Hyperscale AI Data Center Demands

5 days ago

With a focus on energy orchestration software rather than grid hardware or power generation, GridAI addresses the immediate need to…

Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds

1 week ago

Brain tumors may damage surrounding tissue in a more insidious way than previously understood. New research from the University of Notre Dame shows that chronic…

When Cancer Care Hits a Hardware Wall, One Microcap Is Building Around It

1 week ago

In oncology, the biggest constraints are not always science. They are often the logistics, the cost of specialized infrastructure, and…

Existing Cancer Drug Shows Potential in Reactivating Immunotherapy

1 week ago

An already approved cancer drug called Carfilzomib may help restore the effectiveness of CAR-T cell therapy in advanced multiple myeloma cases. Technical…

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Focused on Dual Narratives of Scientific Progress, Social Engagement

2 weeks ago

LIXTE recently announced advances in its approach to cancer therapy through its proprietary compound LB-100 Alongside clinical development news, LIXTE is…